Correlation Between Catalyst Pharmaceuticals and Oak View

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Oak View at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Oak View into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Oak View National, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Oak View and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Oak View. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Oak View.

Diversification Opportunities for Catalyst Pharmaceuticals and Oak View

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Catalyst and Oak is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Oak View National in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oak View National and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Oak View. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oak View National has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Oak View go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and Oak View

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.93 times more return on investment than Oak View. However, Catalyst Pharmaceuticals is 1.93 times more volatile than Oak View National. It trades about 0.05 of its potential returns per unit of risk. Oak View National is currently generating about 0.01 per unit of risk. If you would invest  2,127  in Catalyst Pharmaceuticals on December 20, 2024 and sell it today you would earn a total of  133.00  from holding Catalyst Pharmaceuticals or generate 6.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy83.05%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  Oak View National

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.
Oak View National 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Oak View National has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable forward-looking signals, Oak View is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Catalyst Pharmaceuticals and Oak View Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and Oak View

The main advantage of trading using opposite Catalyst Pharmaceuticals and Oak View positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Oak View can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oak View will offset losses from the drop in Oak View's long position.
The idea behind Catalyst Pharmaceuticals and Oak View National pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum